Open Access

Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort

Respiratory Research20067:142

DOI: 10.1186/1465-9921-7-142

Received: 14 August 2006

Accepted: 05 December 2006

Published: 05 December 2006

Abstract

Background

Several studies have reported an association between asthma and gastro-oesophageal reflux, but it is unclear which condition develops first. The role of obesity in mediating this association is also unclear. We explored the associations between respiratory symptoms, lung function, and gastro-oesophageal reflux symptoms in a birth cohort of approximately 1000 individuals.

Methods

Information on respiratory symptoms, asthma, atopy, lung function and airway responsiveness was obtained at multiple assessments from childhood to adulthood in an unselected birth cohort of 1037 individuals followed to age 26. Symptoms of gastro-oesophageal reflux and irritable bowel syndrome were recorded at age 26.

Results

Heartburn and acid regurgitation symptoms that were at least "moderately bothersome" at age 26 were significantly associated with asthma (odds ratio = 3.2; 95% confidence interval = 1.6–6.4), wheeze (OR = 3.5; 95% CI = 1.7–7.2), and nocturnal cough (OR = 4.3; 95% CI = 2.1–8.7) independently of body mass index. In women reflux symptoms were also associated with airflow obstruction and a bronchodilator response to salbutamol. Persistent wheezing since childhood, persistence of asthma since teenage years, and airway hyperresponsiveness since age 11 were associated with a significantly increased risk of heartburn and acid regurgitation at age 26. There was no association between irritable bowel syndrome and respiratory symptoms.

Conclusion

Reflux symptoms are associated with respiratory symptoms in young adults independently of body mass index. The mechanism of these associations remains unclear.

Background

An association between symptoms of asthma and gastro-oesophageal reflux is now well-recognised, with a number of studies reporting a much higher prevalence of reflux symptoms in patients with asthma than in control subjects [1]. Objective measurements using endoscopy and oesophageal pH monitoring confirm a high prevalence of reflux in asthma [2, 3].

The association between gastro-oesophageal reflux and asthma could have several explanations [4]. Reflux may precipitate asthma, either via a vagal reflex initiated by gastric fluid in the oesophagus, or by micro-aspiration of gastric contents into the trachea. Conversely, asthma may promote reflux due to the increased pressure swings in the thorax during respiration [5, 6]. During 24 hour monitoring of oesophageal pH and asthma symptoms, reflux appeared to precipitate asthma symptoms and cough far more often than asthma precipitated reflux [7]. However, although episodes of gastro-oesophageal reflux might trigger wheezing in an individual who has asthma, this does not necessarily indicate an aetiological association between having reflux disease and the asthmatic phenotype. The association between asthma and reflux could also be mediated by obesity, which is a risk factor for both conditions [811]. Finally, reflux could give rise to asthma-like symptoms, such as nocturnal cough, but have no effect on lung function or airway responsiveness.

Population-based studies of asthma and reflux are rare. A postal questionnaire of British adults confirmed an association between reflux symptoms and symptoms suggestive of bronchial hyperresponsiveness and also found an association between respiratory symptoms and irritable bowel syndrome [12]. The European Community Respiratory Health Study found a strong association between symptoms of nocturnal reflux and asthma and respiratory symptoms in a random sample of young adults. This remained significant after adjustment for body mass index [13]. A recent follow-up study of the same participants 5 – 10 years later, found both obesity and nocturnal reflux symptoms to be independent risk factors for the onset of asthma [14].

We explored the relations between symptoms and objective evidence of asthma, reflux and obesity in the Dunedin Multidisciplinary Health and Development Study – a birth cohort of approximately 1000 individuals followed to age 26. We hypothesised that if asthma predisposes to gastro-oesophageal reflux, then long-standing persistent asthma would be associated with the highest risk of reflux symptoms. Conversely, if reflux precipitates asthma, adult reflux symptoms would be most strongly associated with adult-onset asthma.

Methods

The Dunedin Multidisciplinary Health and Development Study is a cohort study of 1037 children (52% male) born April 1972 to March 1973 [15]. Follow-up assessments have been conducted at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, and 26 years when 980 (96%) of 1019 living study members participated. The Otago Ethics Committee approved the study and written informed consent was obtained at each assessment.

At age 9, the accompanying adult was questioned about current and previous asthma, wheeze and cough [16]. This information was updated at subsequent assessments [17]. Current asthma was defined as diagnosed asthma with at least one episode of asthma or wheezing symptoms within the previous year. Current wheeze was defined current wheeze as episodes of wheezing in the last year, excluding those with only one or two episodes each lasting less than one hour. At age 26 Study members were asked if they had woken with coughing in the previous year when they did not have a cold. Current smoking was defined as smoking daily for at least one month during the past year. Cumulative lifetime smoking history was assessed as total "pack-years" smoked up to age 26 years where one pack-year is the equivalent of smoking one pack of 20 cigarettes every day for a year.

Height without shoes, and weight in light clothing, were measured to calculate Body Mass Index (BMI) in kg/m2. Spirometry to measure the forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) was measured at ages 9, 11, 13, 15 and 21 years using a Godart water-sealed spirometer. At age 18 years spirometry was performed before and after nebulised salbutamol using a Morgan rolling seal spirometer. At age 26 years, spirometry was performed before and after salbutamol 200 μg inhaled from a metered dose inhaler via a valved spacer using a Sensormedics body plethysmograph. Airway responsiveness to methacholine was measured at ages 9, 11, 13, 15 and 21 years using a validated modified Chai protocol [18]. A provoking concentration of methacholine to induce a 20% fall in FEV1 (PC20) of 8 mg/mL or less indicated airway hyperresponsiveness. When methacholine challenge was not undertaken (at ages 18 and 26), or if a low FEV1 precluded testing at other ages for safety reasons, an increase in FEV1 of 10% or greater after inhaling salbutamol (bronchodilator response) was taken as also indicating airway hyperresponsiveness. Skin prick testing at age 21 included house dust mite (Dermatophagoides pteronyssinus), grass, cat, dog, horse, kapok, wool, Aspergillus fumigatus, alternaria, penicillium, and cladosporium [19]. A weal diameter 2 mm greater than saline control was considered positive and atopy was defined as a positive response to one or more allergens.

At age 26 Study members were asked questions from the Bowel Symptom Questionnaire [20]. These included whether they had had "heartburn (a burning pain or discomfort behind the breastbone rising up in the chest)" and if they had had "a bitter or sour tasting fluid that comes to your throat or mouth" (acid regurgitation). Each symptom was scored according to how bothersome it was: 0 = I have not been bothered by this symptom; 1 = A little bit bothersome; 2 = Moderately bothersome; 3 = Quite a bit bothersome; 4 = Extremely bothersome. For this analysis, reflux symptoms were included if they were at least moderately bothersome (score 2 and above).

Irritable bowel syndrome was defined using the Manning criteria [21]. This required abdominal pain or discomfort plus at least two of the following six symptoms: pain relief by defecation, looser stools at the onset of pain, more frequent stools at the onset of pain, abdominal distension, mucus per rectum and feeling of incomplete rectal evacuation. These criteria are highly specific for irritable bowel syndrome [22] and identify more cases than the Rome criteria [23].

Statistical Analysis

Cross-sectional associations between asthma, wheeze, cough, bronchodilator responsiveness and the FEV1/FVC ratio and gastro-intestinal symptoms of heartburn, regurgitation and irritable bowel syndrome at age 26 were analysed by logistic or linear regression using the gastro-intestinal symptoms as the independent (predictor) variables. Heartburn and regurgitation symptoms were considered individually and in combination. All analyses controlled for sex and BMI. Analyses tested for interactions between sex and gastro-intestinal symptoms and, because of known sex differences in the association between body mass index and asthma in this cohort [9], analyses were repeated for each sex separately. We also tested for an interaction between reflux symptoms and atopy. Further analyses adjusted for smoking status.

Longitudinal associations between asthma, wheeze, and airway hyperresponsiveness at earlier ages and reflux symptoms at age 26 were examined by logistic regression. Asthma and wheeze were used as the independent (predictor) variables in these analyses and were categorised according to the age at which they were first reported and whether they were still present at age 26. Thus asthma was classified as "child-persistent" asthma if an asthma diagnosis was first reported at age 9 or 11 and still present at age 26, "teen-persistent" if first reported at age 13, 15 or 18 and still present at age 26, "adult-onset" if first reported at age 21 or 26 and "remittent" if asthma had been reported at an earlier assessment but not at age 26. The same classifications were made for wheezing. Associations between airway hyperresponsiveness at earlier assessments and reflux symptoms were analysed for each age using logistic regression. All analyses adjusted for sex. Further analyses of hyperresponsiveness adjusted for current asthma and symptoms of wheeze.

Pregnant women (n = 33) and Study members with symptoms meeting American Psychiatric Association criteria for eating disorders [24] (n = 25) at age 26 were excluded from all analyses. Analyses were performed using Stata version 9 (Stata corporation, College Station, TX).

Results

Cross-sectional associations at age 26

Heartburn and acid regurgitation symptoms that were at least "moderately bothersome" were reported by 12.5% and 6.0% respectively while 4.1% reported both (table 1). The frequencies of heartburn and acid regurgitation did not differ between men and women whereas irritable bowel syndrome was more common in women than men (20.3% and 13.6% respectively, p = 0.007, 95% CI for difference 1.9–11.6%). The prevalence of respiratory outcomes at age 26 years and the mean FEV1/FVC ratio in those with and without gastrointestinal symptoms are shown in table 1.
Table 1

Prevalence of respiratory outcomes in those with and without reflux symptoms and irritable bowel syndrome at age 26 years

 

% prevalence

% with respiratory condition

Mean FEV1/FVC

  

Asthma

Wheeze

Cough

BDR

 

No Reflux symptoms*

85.8

17.2

35.0

12.4

6.9

81.7 %

Heartburn

12.5

28.3

48.7

23.9

14.2

80.9 %

Regurgitation

6.0

38.9

62.3

35.2

18.0

79.3 %

Heartburn and regurgitation

4.1

43.2

67.6

40.5

22.9

78.9 %

Irritable Bowel Syndrome

16.7

20.4

41.7

13.2

8.4

81.5 %

* excludes anyone reporting either bothersome heartburn or acid regurgitation. BDR (bronchodilator response) = 10% or greater increase in FEV1 following salbutamol.

Heartburn and acid regurgitation symptoms were significantly associated with a diagnosis of asthma, symptoms of wheeze and waking with a cough (table 2). These associations were similar in men and women and were independent of BMI. None of the respiratory outcomes was associated with irritable bowel syndrome.
Table 2

Association of asthma diagnosis and respiratory symptoms with reflux symptoms and irritable bowel syndrome at age 26 years

  

Heartburn

Regurgitation

Heartburn and regurgitation

Irritable Bowel Syndrome

 

n

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

p

Asthma

903

1.75 (1.11, 2.76)

0.017

2.76 (1.54, 4.96)

0.001

3.22 (1.62, 6.40)

0.001

1.10 (0.71, 1.71)

0.67

Wheeze

897

1.65 (1.10, 2.46)

0.015

2.84 (1.59, 5.06)

<0.001

3.53 (1.74, 7.18)

<0.001

1.25 (0.87, 1.79)

0.23

Cough

903

2.02 (1.23, 3.33)

0.005

3.48 (1.88, 6.45)

<0.001

4.27 (2.09, 8.72)

<0.001

0.83 (0.49, 1.40)

0.49

All analyses are by logistic regression using the respiratory outcomes as the dependent variables and are adjusted for sex and body mass index. OR = odds ratio, 95% CI = 95% confidence intervals.

There were significant interactions between sex and acid regurgitation symptoms for the bronchodilator response and the FEV1/FVC ratio and these findings are shown separately for men and women in table 3. In women, but not men, there were significant associations between reflux symptoms and a lower FEV1/FVC ratio and increased bronchodilator responsiveness to salbutamol.
Table 3

Associations between lung function, bronchodilator responsiveness and reflux symptoms and irritable bowel syndrome in women and men.

   

Heartburn

Regurgitation

Heartburn and regurgitation

Irritable Bowel Syndrome

  

n

Coeff (95% CI)

p

Coeff (95% CI)

p

Coeff (95% CI)

P

Coeff (95% CI)

p

FEV1/FVC

Women

402

-0.52 (-2.72, 1.68)

0.643

-5.14 (-8.09, -2.20)

0.001

-5.55 (-9.07, -2.04)

0.002

0.04 (-1.58, 1.65)

0.966

 

Men

464

0.07 (-1.80, 1.94)

0.942

-0.10 (-2.80, 2.61)

0.944

-0.28 (-3.50, 2.95)

0.866

-0.70 (-2.61, 1.21)

0.473

 

p-itn

  

0.609

 

0.013

 

0.029

 

0.618

  

n

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

P

OR (95% CI)

p

BDR

Women

398

3.53 (1.28, 9.70)

0.015

8.74 (2.99, 25.6)

<0.001

11.5 (3.40, 38.6)

<0.001

0.76 (0.25, 2.30)

0.628

 

Men

455

1.67 (0.76, 3.68)

0.199

1.11 (0.32, 3.85)

0.864

1.72 (0.48, 6.13)

0.403

1.59 (0.70, 3.61)

0.270

 

p-itn

  

0.256

 

0.014

 

0.035

 

0.300

The FEV1/FVC ratio is analysed by linear regression and bronchodilator response by logistic regression. Analyses use these as the dependent variables and are adjusted for BMI. Coeff = regression coefficient, OR = odds ratio, 95% CI = 95% confidence intervals, p-itn = p value for interaction between sex and reflux symptoms, BDR = 10% or greater increase in FEV1 following salbutamol.

Atopy (assessed at age 21) was not associated with either heartburn (OR = 0.91, 95% CI: 0.59–1.40, p = 0.67) or regurgitation (OR = 1.04, 95% CI: 0.57–1.90, p = 0.90). The associations between reflux symptoms and asthma diagnosis were not significantly different between those who were atopic and those who were not. However, there were trends to stronger associations between reflux symptoms and wheeze, waking with cough, and bronchodilator responsiveness in those who were not atopic which were of borderline statistical significance (table 4).
Table 4

Associations between reflux symptoms and respiratory outcomes in atopic and non-atopic Study members.

 

Heartburn

Regurgitation

Heartburn and Regurgitation

 

Non-atopic

Atopic

 

Non-atopic

Atopic

 

Non-atopic

Atopic

 
 

OR (95% CI)

OR (95% CI)

p-itn

OR (95% CI)

OR (95% CI)

p-itn

OR (95% CI)

OR (95% CI)

p-itn

Asthma

1.81 (0.64, 5.17)

1.96 (1.12, 3.44)

0.873

4.03 (1.11, 14.5)

2.54 (1.23, 5.24)

0.603

3.51 (0.80, 15.3)

3.16 (1.35, 7.38)

0.827

Wheeze

2.88 (1.40, 5.90)

1.30 (0.76, 2.20)

0.072

7.27 (2.23, 23.7)

1.93 (0.95, 3.93)

0.062

6.56 (1.68, 25.6)

2.54 (1.07, 6.00)

0.253

Cough

4.67 (1.98, 11.0)

1.46 (0.73, 2.92)

0.039

5.90 (1.94, 18.0)

2.88 (1.30, 6.38)

0.315

10.8 (3.02, 38.6)

2.87 (1.12, 7.34)

0.099

BDR

2.81 (0.70, 11.3)

2.08 (0.99, 4.36)

0.760

7.57 (1.76, 32.5)

1.76 (0.64, 4.86)

0.108

12.7 (2.71, 59.6)

2.08 (0.67, 6.50)

0.067

 

Coeff (95% CI)

Coeff (95% CI)

 

Coeff (95% CI)

Coeff (95% CI)

 

Coeff (95% CI)

Coeff (95% CI)

 

FEV1/FVC

0.80 (-1.24, 2.84)

-1.15 (-3.13, -0.82)

0.213

-2.43 (-5.37, 0.51)

-2.27 (-4.95, 0.41)

0.940

-1.91 (-5.34, -1.51)

-2.56 (-5.79, 0.66)

0.808

Non-atopic groups (n = 278) and atopic (n = 536) defined by skin-prick tests at age 21. The FEV1/FVC ratio is analysed by linear regression. All other analyses use logistic regression. Analyses use the respiratory outcomes as the dependent variables and are adjusted for BMI and sex. OR = odds ratio, Coeff = coefficient, 95% CI = 95% confidence intervals, p-itn = p value for interaction between atopic status and reflux symptoms, BDR = 10% or greater increase in FEV1 following salbutamol.

Current smoking was associated with both heartburn (OR = 1.55, 95% CI: 1.04–2.31, p = 0.03) and regurgitation (OR = 1.77, 95% CI: 1.02–3.08, p = 0.04). Adjusting for current smoking or cumulative lifetime pack-year smoking history in addition to sex and BMI did not materially alter any of the analyses.

Longitudinal associations

Reflux symptoms were not significantly more common in those with persistent asthma since childhood, but were significantly increased in those with asthma since their teens and those with adult onset-asthma compared to those who denied ever having asthma (figure 1). Those with a history of asthma which had remitted by age 26 did not have an increased risk of reflux symptoms. By contrast both childhood-persistent and teen-persistent wheeze were significantly associated with adult reflux symptoms (figure 2). Adult-onset wheeze was significantly associated with heartburn symptoms only. Those who had a history of wheeze which had improved by age 26 did not have a significantly increased risk of reflux symptoms.
Figure 1

Prevalence of reflux symptoms at age 26 according to history of asthma. No asthma = denies ever having had asthma by age 26 (n = 543). Child-persistent 9 = asthma reported at age 9 or 11 and also at age 26 (n = 70). Teen-persistent = asthma first reported at age 13, 15 or 18 and still present at age 26 (n = 42). Adult-onset = asthma first reported at age 21 or 26 (n = 78). Asthma remission = asthma reported at an earlier age, but not at 26 (n = 174). * = p < 0.05 compared to no asthma.

Figure 2

Prevalence of reflux symptoms at age 26 according to history of wheeze. No wheeze = denies ever having had wheeze by age 26 (n = 249). Child-persistent = wheeze at age 9 or 11 and also at age 26 (n = 102). Teen- persistent = wheeze first reported at age 13, 15 or 18 and still present at age 26 (n = 127). Adult-onset = wheeze first reported at age 21 or 26 (n = 168). Wheeze remission = wheeze reported at an earlier age, but not at 26 (n = 174). * = p < 0.05 compared to no wheeze.

Airway hyperresponsiveness to methacholine (or bronchodilator responsiveness in those unable to inhale methacholine) at age 9 years was not significantly associated with reflux symptoms at age 26. However, hyperresponsiveness to methacholine at all subsequent ages was significantly and strongly associated with combined heartburn and acid regurgitation symptoms at age 26 (table 5). These associations were independent of a current asthma diagnosis or current wheeze symptoms at the age at which the methacholine challenge was undertaken (data not shown). There was no association between responsiveness to salbutamol at age 18 and reflux symptoms at age 26. The findings were similar if these analyses excluded the Study members who had had responsiveness to salbutamol measured instead of methacholine challenges at ages 9, 11, 13, 15 and 21 for safety reasons.
Table 5

Prediction of reflux symptoms at age 26 years by history of airway hyperresponsiveness.

    

Heartburn

Regurgitation

Heartburn and regurgitation

Challenge agent

Age

n

% with AHR

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

p

Methacholine*

9

716

16.9

1.40 (0.81, 2.43)

0.234

1.22 (0.55, 2.73)

0.623

1.51 (0.63, 3.61)

0.354

 

11

677

10.8

1.62 (0.84, 3.11)

0.150

1.89 (0.80, 4.48)

0.147

3.00 (1.22, 7.40)

0.017

 

13

637

8.3

1.63 (0.76, 3.51)

0.210

1.78 (0.66, 4.82)

0.253

2.92 (1.04, 8.17)

0.041

 

15

743

8.3

1.92 (1.00, 3.70)

0.051

2.94 (1.35, 6.42)

0.007

3.86 (1.66, 8.97)

0.002

 

21

795

7.7

2.59 (1.38, 4.85)

0.003

4.61 (2.26, 9.40)

<0.001

5.56 (2.53, 12.2)

<0.001

Salbutamol

18

758

7.8

1.01 (0.46, 2.21)

0.978

1.13 (0.39, 3.29)

0.818

1.14 (0.34, 3.85)

0.836

At age 18 years, responsiveness to salbutamol bronchodilator was measured. At ages 9, 11, 13, 15 and 21 years responsiveness to methacholine was measured unless a low FEV1 precluded methacholine challenge. Airway hyperresponsiveness (AHR) was defined as a PC20 methacholine of 8 mg/mL or less or an increase in FEV1 of 10% or bronchodilator. OR = odds ratio, 95% CI = 95% confidence intervals. Analyses are by logistic regression using reflux symptoms as the dependent variables and are adjusted for sex.

Discussion

This study confirms that there is a strong association between symptoms of gastro-oesophageal reflux and symptoms of asthma in this population-based cohort of young adults. These associations were independent of BMI and smoking. Acid regurgitation tended to be a stronger predictor of respiratory symptoms than heartburn, but those with both heartburn and acid regurgitation had the highest risk of respiratory symptoms. The association of reflux symptoms with objective indicators of respiratory function was different for men and women. In women both bronchodilator responsiveness and a lower FEV1/FVC ratio were associated with reflux symptoms, whereas in men there was little evidence of an association. The reasons for these sex differences are unclear.

Although this study provides longitudinal follow-up of asthma, wheeze and airway responsiveness since childhood, data on gastro-oesophageal reflux symptoms were not collected during childhood or adolescence and we are unable to establish the temporal sequence between respiratory symptoms and airway responsiveness and gastro-oesophageal reflux. However, symptomatic gastro-oesophageal reflux is uncommon in children and adolescents after infancy [25]. We hypothesised that if asthma precipitates gastro-oesophageal reflux, there would be strong associations between childhood persistent asthma and reflux symptoms. Although childhood wheeze (but not asthma) did significantly predict adult reflux symptoms (figures 1 and 2), teenage-onset asthma and wheeze were better predictors of adult reflux symptoms suggesting that the association between airway and oesophageal dysfunction emerges or strengthens during adolescence. This is supported by the association between airway hyperresponsiveness to methacholine from age 11 onwards and adult reflux symptoms. The strongest association between diagnosed asthma and reflux symptoms was in those with adult-onset asthma, but the findings for wheeze and airway responsiveness are consistent with the hypothesis that longstanding wheeze contributes to the development of reflux, even though it may not have been diagnosed as "asthma".

Perhaps the most striking finding was that airway hyperresponsiveness to methacholine at age 11 years and older predicted the combination of heartburn and acid regurgitation symptoms 15 years later (table 5). These associations were generally similar in males and females (data not shown). By contrast, there was no association between bronchodilator responsiveness at age 18 and adult reflux, while the cross-sectional association between bronchodilator responsiveness and reflux at age 26 was significant in women only. The association between methacholine responsiveness at age 9 and adult reflux was not statistically significant. Methacholine responsiveness was more common at this age and often asymptomatic. For many, this was a self-limiting phenomenon, and long-term associations would not be expected.

Why methacholine responsiveness in later childhood and adolescence predicts gastro-oesophageal reflux symptoms years later is unknown. Episodes of airway narrowing may lead to increased pressure swings in the thorax during the respiratory cycle and promote failure of the gastro-oesophageal sphincter [26]. However, the association was independent of both diagnosed asthma and wheezing symptoms, which suggests that frequent episodes of bronchoconstriction were an unlikely cause of the association. Alternatively, the two phenomena may be linked by altered vagal function, since the vagus nerve controls lower oesophageal tone as well as airway calibre and responsiveness. Autonomic function tests in patients with both asthma and gastro-oesophageal reflux have demonstrated heightened vagal tone, but it is unclear if this was a primary abnormality or a consequence of either asthma, gastro-oesophageal reflux or their treatment [27].

It is possible that the long-term association between teenage methacholine responsiveness and adult reflux symptoms is due to persistence of gastro-oesophageal reflux since adolescence. Although gastro-oesophageal reflux is thought to be uncommon in children and adolescents [25], this may be because it is poorly recognised. In a recent cross-sectional survey, 6% of 13 and 14 year-olds reported having either heartburn or regurgitation symptoms at least once a week in the previous month [28]. Consistent with our findings, reflux symptoms were much more common in the children with asthma. Moreover gastro-oesophageal reflux is often asymptomatic and even "silent" reflux is associated with asthma [29, 30]. Several studies have reported improvements in asthma symptoms or lung function after medical or surgical treatment for gastro-oesophageal reflux. Although a recent systematic review found that the evidence was inconsistent and concluded that there was no overall benefit, sub-groups of patients may benefit [31].

The finding that the association between wheeze, waking with a cough, and bronchodilator responsiveness and reflux symptoms tended to be stronger in those who were not atopic would support a hypothesis that gastro-oesophageal reflux causes these symptoms by a mechanism which is distinct from the classic atopic/immunological model of asthma.

The associations between reflux symptoms and asthma were independent of BMI, confirming the finding from the European Community Respiratory Health Survey [13]. This is an important observation since gastro-oesophageal reflux has been suggested as a plausible mechanism for the association between asthma and obesity, particularly since the associations between obesity and both asthma and reflux are stronger in women and because oestrogen has been implicated in both [10, 11]. We have previously identified an association between asthma and BMI in women in this cohort [9]. This association between asthma and BMI was not materially altered by including reflux symptoms in the model indicating that reflux does not mediate the asthma-obesity association (data not shown). Perhaps this is not surprising since reflux symptoms in this young adult cohort were only weakly associated with obesity [32].

We found little evidence of an association between asthma and irritable bowel syndrome, which suggests that the association between asthma and gastro-intestinal symptoms is specific for gastro-oesophageal reflux and not a more generalised functional gastro-intestinal disorder. This finding contrasts with results from the postal survey by Kennedy et al which found that symptoms of bronchial hyperresponsiveness, irritable bowel syndrome and gastro-oesophageal reflux were all significantly and independently associated with each other [12]. The survey by Kennedy et al used a randomly selected sample of adults with a mean age of 38, 12 years older than the participants of this cohort. Moreover, they did not measure lung function but used symptoms to predict bronchial responsiveness.

Strengths of this study include a high rate of follow-up in a population based cohort, prospectively collected data on asthma since childhood, measurements of lung function and airway responsiveness, and directly measured rather than self-reported height and weight. Our findings are coherent across a range of indicators of asthma including a reported diagnosis, wheezing symptoms, and methacholine responsiveness, as well as the symptom of nocturnal cough which could be caused by either asthma or gastro-oesophageal reflux. For women there is also coherence with spirometry and salbutamol-responsiveness. Weaknesses of this study include the fact that detailed information on reflux symptoms was only collected at age 26, and that a subjective measure of "bothersome" symptoms was used to indicate clinically significant reflux. Hence we do not know when these symptoms first occurred, nor do we have data on symptom frequency. However, these factors would reduce the likelihood of identifying significant associations and therefore it is unlikely that these limitations have biased our findings.

Conclusion

Heartburn and acid regurgitation symptoms are associated with asthma diagnosis, wheeze, and morning cough in this population-based birth cohort followed to age 26. In women, reflux symptoms are also associated with bronchodilator responsiveness and airflow obstruction. The associations were independent of BMI and smoking and tended to be stronger in non-atopic individuals. Early-onset persistent wheeze and airway hyperresponsiveness were associated with adult reflux symptoms. The mechanism of the association warrants further investigation.

Abbreviations

BDR: 

Bronchodilator response

BMI: 

Body Mass Index

95% CI: 

95% confidence intervals for mean

FEV1

Forced Expiratory Volume in one second

FVC: 

Forced Vital Capacity

OR: 

Odds Ratio

PC20

Provoking Concentration to induce a 20% fall in FEV1

Declarations

Acknowledgements

We are grateful to the Study members and their families and friends for their continued support. We also thank Dr Phil A Silva, the study founder. The Dunedin Multidisciplinary Health and Development Research Unit is funded by the Health Research Council of New Zealand. The respiratory section of the Study was funded by the Health Research Council, the Otago Medical Research Foundation, the New Zealand Lottery Grants Board and the Asthma Foundation of New Zealand. These funding sources had no role in the design, analysis, interpretation, writing or decision to publish this report.

Authors’ Affiliations

(1)
Dunedin Multidisciplinary Health and Development Research Unit, Dunedin School of Medicine, University of Otago
(2)
Department of Medical and Surgical Sciences, Dunedin School of Medicine, University of Otago
(3)
Firestone Institute for Respiratory Health, Department of Medicine, McMaster University
(4)
Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago
(5)
Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, and Internal Medicin, Mayo Clinic, Rochester Foundation

References

  1. Richter JE: Gastroesophageal reflux disease and asthma: the two are directly related. Am J Med 2000, 108 Suppl 4a:153S-158S.View ArticlePubMedGoogle Scholar
  2. Sontag SJ, O'Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R: Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990,99(3):613–620.View ArticlePubMedGoogle Scholar
  3. Sontag SJ, Schnell TG, Miller TQ, Khandelwal S, O'Connell S, Chejfec G, Greenlee H, Seidel UJ, Brand L: Prevalence of oesophagitis in asthmatics. Gut 1992,33(7):872–876.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Sontag SJ: Why do the published data fail to clarify the relationship between gastroesophageal reflux and asthma? Am J Med 2000, 108 Suppl 4a:159S-169S.View ArticlePubMedGoogle Scholar
  5. Harding SM: Gastroesophageal reflux, asthma, and mechanisms of interaction. Am J Med 2001, 111 Suppl 8A:8S-12S.View ArticlePubMedGoogle Scholar
  6. Moote DW, Lloyd DA, McCourtie DR, Wells GA: Increase in gastroesophageal reflux during methacholine-induced bronchospasm. J Allergy Clin Immunol 1986,78(4 Pt 1):619–623.View ArticlePubMedGoogle Scholar
  7. Harding SM, Guzzo MR, Richter JE: 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 1999,115(3):654–659.View ArticlePubMedGoogle Scholar
  8. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999,106(6):642–649.View ArticlePubMedGoogle Scholar
  9. Hancox RJ, Milne BJ, Poulton R, Taylor DR, Greene JM, McLachlan CR, Cowan JO, Flannery EM, Herbison GP, Sears MR: Sex Differences in the Relation between Body Mass Index and Asthma and Atopy in a Birth Cohort. Am J Respir Crit Care Med 2005,171(5):440–445.View ArticlePubMedGoogle Scholar
  10. Weiss ST, Shore S: Obesity and asthma: directions for research. Am J Respir Crit Care Med 2004,169(8):963–968.View ArticlePubMedGoogle Scholar
  11. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J: Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003,290(1):66–72.View ArticlePubMedGoogle Scholar
  12. Kennedy TM, Jones RH, Hungin AP, O'Flanagan H, Kelly P: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998,43(6):770–774.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Gislason T, Janson C, Vermeire P, Plaschke P, Bjornsson E, Gislason D, Boman G: Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest 2002,121(1):158–163.View ArticlePubMedGoogle Scholar
  14. Gunnbjornsdottir MI, Omenaas E, Gislason T, Norrman E, Olin AC, Jogi R, Jensen EJ, Lindberg E, Bjornsson E, Franklin K, Janson C, Gulsvik A, Laerum B, Svanes C, Toren K, Tunsater A, Lillienberg L, Gislason D, Blondal T, Bjornsdottir US, Jorundsdottir KB, Talvik R, Forsberg B, Franklin K, Lundback B, Soderberg M, Ledin MC, Boman G, Norback D, Wieslander G, Spetz-Nystrom U, Cashelunge KS, Ryden E: Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 2004,24(1):116–121.View ArticlePubMedGoogle Scholar
  15. Silva PA, Stanton WR: From child to adult: The Dunedin Multidisciplinary Health and Development Study. Auckland , Oxford University Press; 1996.Google Scholar
  16. Jones DT, Sears MR, Holdaway MD, Hewitt CJ, Flannery EM, Herbison GP, Silva PA: Childhood asthma in New Zealand. Br J Dis Chest 1987,81(4):332–340.View ArticlePubMedGoogle Scholar
  17. Sears MR, Greene JM, Willan A, Wiecek E, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R: A longitudinal population-based cohort study of childhood asthma followed to adulthood. New Engl J Med 2003, 349:1414–1422.View ArticlePubMedGoogle Scholar
  18. Sears MR, Jones DT, Holdaway MD, Hewitt CJ, Flannery EM, Herbison GP, Silva PA: Prevalence of bronchial reactivity to inhaled methacholine in New Zealand chldren. Thorax 1986, 41:283–289.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Sears MR, Greene JM, Willan A, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Poulton R: Long-term relation between breast-feeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet 2002,360(9337):901–907.View ArticlePubMedGoogle Scholar
  20. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ: Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 1995,25(4):302–308.View ArticlePubMedGoogle Scholar
  21. Manning AP, Thompson WG, Heaton KW, Morris AF: Towards positive diagnosis of the irritable bowel. Br Med J 1978,2(6138):653–654.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR: Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990,31(1):77–81.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd: A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000,95(10):2816–2824.View ArticlePubMedGoogle Scholar
  24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC.; 1994.Google Scholar
  25. Ruigomez A, Garcia Rodriguez LA, Wallander MA, Johansson S, Graffner H, Dent J: Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004,20(7):751–760.View ArticlePubMedGoogle Scholar
  26. Zerbib F, Guisset O, Lamouliatte H, Quinton A, Galmiche JP, Tunon-De-Lara JM: Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am J Respir Crit Care Med 2002,166(9):1206–1211.View ArticlePubMedGoogle Scholar
  27. Lodi U, Harding SM, Coghlan HC, Guzzo MR, Walker LH: Autonomic regulation in asthmatics with gastroesophageal reflux. Chest 1997,111(1):65–70.View ArticlePubMedGoogle Scholar
  28. Debley JS, Carter ER, Redding GJ: Prevalence and impact of gastroesophageal reflux in adolescents with asthma: A population-based study. Pediatr Pulmonol 2006,41(5):475–481.View ArticlePubMedGoogle Scholar
  29. Buts JP, Barudi C, Moulin D, Claus D, Cornu G, Otte JB: Prevalence and treatment of silent gastro-oesophageal reflux in children with recurrent respiratory disorders. Eur J Pediatr 1986,145(5):396–400.View ArticlePubMedGoogle Scholar
  30. Harding SM, Guzzo MR, Richter JE: The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 2000,162(1):34–39.View ArticlePubMedGoogle Scholar
  31. Gibson PG, Henry RL, Coughlan JL: Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003, CD001496.Google Scholar
  32. Talley NJ, Howell S, Poulton R: Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol 2004,99(9):1807–1814.View ArticlePubMedGoogle Scholar

Copyright

© Hancox et al. 2006

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement